Join us in celebrating the 2022 Innovation Awards that showcase the top drug development and manufacturing technologies of the year! In My View articles this issue cover best practices for embracing digitization and words of wisdom on mRNA manufacturing challenges. We also cover the role of automation in cell and gene therapy, trends in antibody drug conjugates, and how catalysts are contributing to a greener future. Brian Mullan of Yposkesi looks at the gaps in gene therapy manufacturing prowess and we also sit down with Gen Li from Phesi.
December 7, 2022
We all know that automation can reduce human labor, but how else can it make economically viable cell and gene therapies a reality?
7 min read
November 30, 2022
Walking through the mRNA manufacturing process – and its many challenges
4 min read
November 24, 2022
Researchers examine how combination therapies for malaria lead to drug resistance
4 min read
November 23, 2022
A growing number of deaths linked to pediatric medicines prompts the WHO to investigate “unacceptable” levels of APIs.
2 min read
November 17, 2022
Israel Lowy, SVP, Translational and Clinical Sciences, Oncology, at Regeneron Pharmaceuticals, explains how a positive CHMP opinion can become good news for cancer patients
3 min read
October 13, 2022
Investing in a robust, fulfilling company culture is the best way to thrive in the current challenging recruitment landscape and to achieve long-term success as the biotech industry inevitably rebounds
6 min read
October 6, 2022
The pharma industry is steaming ahead with the development of new medicines and technologies, but is it attracting the talent it needs to continue its current success? Industry experts share their tips on how companies can improve their hiring tactics…
5 min read
September 20, 2022
It’s time for quality and manufacturing to go paperless, but how should a company go about digitization?
4 min read
July 18, 2022
To meet increasing global demand for more efficient and greener processes, environmentally friendly catalyst technologies are on the rise
5 min read
